R3 Bio's Stealth Pitch: Brainless Human Clones as Backup Bodies
Stealth biotech firm R3 Bio didn't just fund monkey 'organ sacks'—its founder eyed brainless human clones as eternal spare parts. Ethics alarms blare as markets weigh the taboo.
⚡ Key Takeaways
- R3 Bio's monkey organ sacks fundraise masks deeper human clone ambitions, risking ethics backlash.
- 'Mother' device sustains uterus ex vivo for a day, opening doors to ectogenesis and better IVF.
- Biotech markets favor safer innovations amid cloning taboos—expect regulatory clamps.
🧠 What's your take on this?
Cast your vote and see what Legal AI Beat readers think
Worth sharing?
Get the best Legal Tech stories of the week in your inbox — no noise, no spam.
Originally reported by MIT Tech Review